Stephen Bagley

4.7k total citations · 1 hit paper
104 papers, 2.0k citations indexed

About

Stephen Bagley is a scholar working on Genetics, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Stephen Bagley has authored 104 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Genetics, 47 papers in Oncology and 32 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Stephen Bagley's work include Glioma Diagnosis and Treatment (53 papers), Radiomics and Machine Learning in Medical Imaging (22 papers) and Cancer Immunotherapy and Biomarkers (20 papers). Stephen Bagley is often cited by papers focused on Glioma Diagnosis and Treatment (53 papers), Radiomics and Machine Learning in Medical Imaging (22 papers) and Cancer Immunotherapy and Biomarkers (20 papers). Stephen Bagley collaborates with scholars based in United States, Switzerland and United Kingdom. Stephen Bagley's co-authors include Donald M. O’Rourke, Arati Desai, Corey J. Langer, Gerald P. Linette, Joshua Bauml, Carl H. June, Charu Aggarwal, Jeffrey C. Thompson, Steven Brem and Tracey L. Evans and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PEDIATRICS.

In The Last Decade

Stephen Bagley

92 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer

2017 387 citations Stephen Bagley, Shawn Kothari et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen Bagley United States	21	1.0k	631	470	410	401	104	2.0k
Seema Nagpal United States	27	828 0.8×	1.0k 1.6×	1.1k 2.3×	319 0.8×	432 1.1×	129	2.8k
Matthias Holdhoff United States	27	604 0.6×	821 1.3×	348 0.7×	248 0.6×	596 1.5×	111	2.1k
April F. Eichler United States	20	1.1k 1.1×	1.0k 1.6×	1.2k 2.6×	194 0.5×	689 1.7×	33	2.7k
Marc Salzberg Switzerland	17	584 0.6×	363 0.6×	491 1.0×	218 0.5×	772 1.9×	39	2.1k
Jimmy Ruiz United States	28	991 1.0×	545 0.9×	1.1k 2.3×	210 0.5×	562 1.4×	103	2.2k
Katherine E. Warren United States	33	513 0.5×	1.7k 2.6×	395 0.8×	157 0.4×	892 2.2×	116	3.0k
Christopher D. Willey United States	28	777 0.8×	329 0.5×	528 1.1×	349 0.9×	1.2k 3.1×	118	2.5k
Joohee Sul United States	17	491 0.5×	912 1.4×	565 1.2×	138 0.3×	365 0.9×	26	1.7k
Gordana Vlahovic United States	26	2.2k 2.2×	1.1k 1.7×	956 2.0×	973 2.4×	920 2.3×	93	3.9k
Sridhar Epari India	23	288 0.3×	783 1.2×	360 0.8×	143 0.3×	599 1.5×	198	1.9k

Countries citing papers authored by Stephen Bagley

Since Specialization

Citations

This map shows the geographic impact of Stephen Bagley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Bagley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Bagley more than expected).

Fields of papers citing papers by Stephen Bagley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Bagley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Bagley. The network helps show where Stephen Bagley may publish in the future.

Co-authorship network of co-authors of Stephen Bagley

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Bagley. A scholar is included among the top collaborators of Stephen Bagley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Bagley. Stephen Bagley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wills, Carson A., Suyash Mohan, Ali Nabavizadeh, et al.. (2025). A single-arm phase 2 study of abemaciclib in adult patients with recurrent grade 3 oligodendroglioma. Neuro-Oncology Advances. 7(1). vdaf011–vdaf011.

Binder, Zev A., Stephen Bagley, Jessica Foster, & Donald M. O’Rourke. (2025). The development of CAR T cells for patients with CNS malignancies. Nature Reviews Clinical Oncology. 23(2). 137–150.

Desai, Arati, et al.. (2025). Response Assessment in Long-Term Glioblastoma Survivors Using a Multiparametric MRI-Based Prediction Model. Brain Sciences. 15(2). 146–146.

Madsen, Peter J., Pedro R. Löwenstein, Maria G. Castro, et al.. (2024). The transformative potential of mRNA vaccines for glioblastoma and human cancer: technological advances and translation to clinical trials. Frontiers in Oncology. 14. 1454370–1454370. 6 indexed citations

Mikolajewicz, Nicholas, Patricia Yee, Alexandra Miller, et al.. (2024). Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical Application. Journal of Clinical Oncology. 42(16). 1961–1974. 13 indexed citations

Yang, Fan, Duo Zhang, Rakan El‐Mayta, et al.. (2024). An immunosuppressive vascular niche drives macrophage polarization and immunotherapy resistance in glioblastoma. Science Advances. 10(9). eadj4678–eadj4678. 17 indexed citations

Logun, Meghan, Stephen Bagley, Daniel Zhang, et al.. (2023). CTIM-40. EARLY RADIOGRAPHIC RESPONSE AND ENGRAFTMENT OF PHASE I FIRST-IN-HUMAN BICISTRONIC CAR T CELLS CORRELATE WITH REAL-TIME AUTOLOGOUS GBM ORGANOID CYTOLYSIS. Neuro-Oncology. 25(Supplement_5). v72–v72. 1 indexed citations

Kothari, Shawn, Abigail Doucette, Daniel Y. Zhang, et al.. (2023). RNA fusion transcript panel identifies diverse repertoire of fusions in adult glioma patients with therapeutic implications. Neuro-Oncology Practice. 10(4). 370–380. 2 indexed citations

Till, Jacob E., Ali Nabavizadeh, Arati Desai, et al.. (2023). BIOM-41. CITRULLINATED HISTONE H3 ELISA REVEALS NETOSIS AS A SOURCE OF PROGNOSTIC CIRCULATING CELL-FREE DNA IN GLIOBLASTOMA. Neuro-Oncology. 25(Supplement_5). v13–v13.

10.

Nabavizadeh, Ali & Stephen Bagley. (2023). Exploiting Iron Metabolism as a Therapeutic Vulnerability in Glioblastoma. Clinical Cancer Research. 30(2). 255–256. 2 indexed citations

11.

Khalili, Nastaran, Anahita Fathi Kazerooni, Ariana Familiar, et al.. (2023). Adding Value to Liquid Biopsy for Brain Tumors: The Role of Imaging. Cancers. 15(21). 5198–5198. 7 indexed citations

12.

Bagley, Stephen, Shawn Kothari, Rifaquat Rahman, et al.. (2021). Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement. Clinical Cancer Research. 28(4). 594–602. 104 indexed citations

13.

Kazerooni, Anahita Fathi, Stephen Bagley, Hamed Akbari, et al.. (2021). Applications of Radiomics and Radiogenomics in High-Grade Gliomas in the Era of Precision Medicine. Cancers. 13(23). 5921–5921. 42 indexed citations

14.

Yang, Fan, Zhenqiang He, Hao Duan, et al.. (2021). Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40. Nature Communications. 12(1). 3424–3424. 114 indexed citations

15.

Bagley, Stephen, Seyed Ali Nabavizadeh, Jacob E. Till, et al.. (2019). Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study. Clinical Cancer Research. 26(2). 397–407. 81 indexed citations

16.

Kluger, Benzi M., Douglas Ney, Stephen Bagley, et al.. (2019). Top Ten Tips Palliative Care Clinicians Should Know When Caring for Patients with Brain Cancer. Journal of Palliative Medicine. 23(3). 415–421. 6 indexed citations

17.

Bagley, Stephen & Donald M. O’Rourke. (2019). Clinical investigation of CAR T cells for solid tumors: Lessons learned and future directions. Pharmacology & Therapeutics. 205. 107419–107419. 100 indexed citations

18.

Marmarelis, Melina E., Erin M. Bange, Stephen Bagley, et al.. (2018). P1.01-64 Impact of STK11 Co-Mutation on Outcomes Following Immunotherapy Among Patients with TP53 and KRAS Mutated Stage IV NSCLC. Journal of Thoracic Oncology. 13(10). S486–S486. 2 indexed citations

19.

Katz, Sharyn I., Mark M. Hammer, Stephen Bagley, et al.. (2018). Radiologic Pseudoprogression during Anti–PD-1 Therapy for Advanced Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 13(7). 978–986. 75 indexed citations

20.

Kothari, Shawn, Stephen Bagley, Charu Aggarwal, et al.. (2017). P3.02c-029 Immune-Related Adverse Events and Their Effect on Outcomes in Patients (pts) with Non-Small Cell Lung Cancer (NSCLC) Treated with Nivolumab. Journal of Thoracic Oncology. 12(1). S1290–S1290. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact